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Abstract 
Lethargy is a frequent and important clinical feature of anaemia; however, it does not absolutely correlate with the 
severity of anaemia. Manganese is efficiently absorbed through the gastrointestinal tract via divalent metal transporter 
1 (DMT1), which is also responsible for iron transport. DMT1 is upregulated in iron deficiency (ID). Increased 
manganese concentrations are reported in ID anaemia (IDA) in various species. Manganese is neurotoxic and therefore 
may contribute to lethargy observed in some anaemic patients. In addition, anaemia and ID are common in human 
inflammatory bowel disease. Little is known about how anaemia influences manganese metabolism in veterinary 
patients and how common is anaemia in dogs with chronic enteropathy (CE). If elevated manganese concentrations 
are found, then potentially neurotoxicity may be contributing to morbidity in these cases. The objectives of this study 
were to investigate the hypothesis that whole blood manganese concentrations would be increased in dogs with 
anaemia, particularly in dogs with confirmed IDA, and that anaemia would be common in canine CE. Medical records 
from 2012-2016 were reviewed for dogs with CE that were anaemic, as well as dogs with confirmed IDA, where a 
sample suitable for manganese analysis was held in an archive. Manganese concentration was measured in whole 
blood from: 11 anaemic dogs with CE, 6 dogs with IDA, 9 non-anaemic ill controls, and 12 healthy controls. Mann-
Whitney U and Kruskal-Wallis tests with post-test Dunn’s multiple comparisons tests were performed, with P<0.05 
considered significant. The prevalence of anaemia in canine CE was 20.6% (33/160). Manganese concentrations were 
significantly different between all groups (P=0.0001) and higher in non-anaemic than anaemic dogs (P=0.0078). 
Manganese concentrations were also higher in healthy compared to ill controls (P<0.0001), anaemic dogs with CE 
(P=0.0056) and to dogs with IDA (P=0.0001). No differences were observed between anaemic dogs with CE, IDA 
and ill controls. Although anaemia was frequently observed in canine CE, the hypothesis that dogs with anaemia 
would have increased manganese concentrations, possibly contributing to a lethargic state was not supported. Further 
research is warranted to understand the influence of anaemia on whole blood manganese. 




Lethargy is a common clinical sign in anaemia. 
Although the reduction in haemoglobin concentration 
results in decreased delivery of oxygen to tissues, 
lethargy does not always correlate with anaemia 
severity (Chervier et al., 2012; Bager, 2014). 
Therefore, it is possible that other factors might be 
contributing to lethargy. In humans with iron 
deficiency anaemia (IDA), increased intestinal iron 
absorption also results in increased absorption of other 
trace elements including manganese (Mn) (Meltzer et 
al., 2010). Manganese is an essential trace element and 
a necessary cofactor for a few enzymes and metabolic 
pathways. Manganese is efficiently absorbed from the 
gastrointestinal tract via divalent metal transporter 1 
(DMT1), which is concurrently responsible for iron 
transport (Au et al., 2008).  
Iron deficiency (ID) causes upregulation of DMT1 and 
has been associated with increased Mn concentrations 
in many species (Kim and Lee, 2011; Smith et al., 
2013).  
Manganese is neurotoxic when present in excessive 
concentrations (Racette et al., 2017). The mechanism 
of neurotoxicity appears multifactorial. Astrocytic 
dysfunction occurs due to their high affinity transport 
system accumulating high intracellular concentrations 
of Mn (Yin et al., 2008). Manganese also causes 
microglial activation by induction of cytokines and 
reactive oxygen species (Dodd and Filipov, 2011), as 
well as causing disruption of several neurotransmitters 
and mitochondrial dysfunction, culminating in 
neuronal apoptosis (Smith et al., 2017).  
Hyperintensity of the basal ganglia on magnetic 
resonance imaging (MRI) is pathognomonic for Mn 
deposition in humans, correlating with neurological 
signs and fatigue in human cirrhosis as well as blood 
Mn concentrations (Burkhard et al., 2003; Forton et al., 
2004). Hyperintensity in focal areas of the basal ganglia 
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has also been shown in canine and feline congenital 
portosystemic shunts, which contained increased 
concentrations of Mn on post-mortem examination 
(Torisu et al., 2008). 
Iron deficiency has been linked with Mn accumulation 
within the brain, and increased uptake by astrocytes, 
mediated by DMT1 upregulation, in the absence of Mn 
overexposure (Erikson and Aschner, 2006). The 
presence of clinical Mn neurotoxicity with concurrent 
ID, and without Mn exposure, has been suggested in 
developing mice and confirmed in one child (Kwik-
Uribe et al., 1999; Brna et al., 2011).  
Anaemia is one of the most common extra-intestinal 
clinicopathological abnormalities in human 
inflammatory bowel disease (IBD), associated with a 
multifactorial aetiology, however over half of the cases 
demonstrated ID (Filmann et al., 2014). Notably, ID is 
suggested to affect quality of life in human IBD, even 
in the absence of anaemia (Herrera-deGuise et al., 
2016).  
There are only a few studies examining Mn 
homeostasis in human IBD. One report demonstrated 
higher whole blood Mn levels in 5/55 patients with 
ulcerative colitis, not associated with clinical or MRI 
evidence of toxicity, with 2/5 cases confirming low 
ferritin levels (El Muhtaseb et al., 2007). The remaining 
studies have shown no differences, though all reports 
were based in serum or plasma Mn (Whineray et al., 
2000; Ma et al., 2013). More importantly, none have 
concentrated specifically on anaemic, or iron deficient 
subjects. 
Chronic enteropathies (CE) are a common cause of 
morbidity and mortality in dogs (Allenspach et al., 
2016). Metabolic complications are well described in 
dogs with CE, notably hypoalbuminaemia, 
hypocobalaminaemia and altered vitamin D status 
(Allenspach et al., 2007; Gow et al., 2011). Canine CE 
appears to share similarities to human IBD (Cerquetella 
et al., 2010). Surprisingly, studies characterising 
anaemia in canine CE are scant, although a prevalence 
is reported of between 12-18% in studies with relatively 
small numbers (Craven et al., 2004; Marchetti et al., 
2010). Essential trace elements in canine CE are even 
less well studied, with only one abstract reporting 
plasma Mn concentrations, showing no difference 
compared to laboratory beagle controls (Yokoyama et 
al., 2016). 
Given the high prevalence of anaemia in human IBD, 
the aim of this study was to investigate the prevalence 
of anaemia in a larger number of cases of canine CE, 
and to then establish whether anaemia is associated 
with increased Mn concentrations. An additional aim 
was to assess if confirmed absolute IDA, regardless of 
underlying aetiology, is associated with higher Mn 
concentrations. Non-anaemic controls, both ill and 
healthy, served as cohorts for comparison. 
Materials and Methods 
Samples 
The small animal teaching hospital archive, at the 
authors’ institution, was used to retrieve the samples for 
the study. The archive database of -80oC stored residual 
samples previously taken for clinical diagnostic 
purposes, with informed consent from the owners, was 
searched for ethylenediaminetetraacetic acid (EDTA) 
samples from January 2012 to January 2016.  
Inclusion criteria 
Using the corresponding patients’ case numbers, a 
retrospective search using the hospital’s electronic 
record system was undertaken to retrieve clinical 
information that would match inclusion criteria for each 
group: anaemic dogs with a clinical diagnosis of CE, 
either food responsive, antibiotic responsive or 
idiopathic, confirmed histologically from endoscopic 
or full thickness surgical gastric and/or intestinal 
biopsies; dogs with absolute IDA; ill dogs with normal 
haematology; and healthy dogs based on history and 
physical examination, with a normal packed cell 
volume (PCV). Mn analysis was performed on small 
cohorts of the first and last two groups, and on all 
patients with confirmed IDA. 
Analyses 
Gastrointestinal histology and haematology analyses 
were performed by the institution’s pathology 
laboratory, with results confirmed by board-certified 
veterinary pathologists and clinical pathologists, 
respectively. Histological results confirming a 
diagnosis of CE would need to include mild, moderate 
or marked mucosal infiltration by inflammatory cells 
(lymphocytes, plasma cells, eosinophils). Anaemia was 
defined by a PCV below the lower limit of the 
laboratory reference range (0.39 L/L). Iron status 
analyses were performed by an external laboratory and 
diagnosis of absolute ID was defined by serum iron 
below the reference interval, combined with transferrin 
saturation below the reference interval and a normal 
total iron binding capacity (TIBC). 
Manganese concentrations were prospectively 
determined at an external laboratory, by graphite 
furnace atomic absorption spectrometry (1100 
Spectrometer, PerkinElmer Life and Analytical 
Sciences, Milan, Italy), in whole blood anticoagulated 
with EDTA, after dilution with Triton X-100 solution 
(Sigma-Aldrich, St. Louis, MO). All samples had been 
frozen within 4 hours of collection, archived as 
abovementioned, and subsequently shipped in dry ice 
to the reference laboratory. The assay had a limit of 
quantitation of 16nmol/L, an inter-assay coefficient of 
variation (CV) of 3.1% and an intra-assay CV of 5.4%.  
Statistical analysis 
Assessment for normality was performed with the 
Kolmogorov-Smirnov test for each group and the 
overall population regarding Mn concentrations, PCV 
http://www.openveterinaryjournal.com 




and age. As not all groups were normally distributed in 
each of the three categories, nonparametric tests were 
therefore used for statistical analysis throughout, with 
data expressed as median (minimum/maximum 
ranges). Mann-Whitney U and Kruskal-Wallis tests 
with post-test Dunn’s multiple comparisons tests were 
performed for assessment of differences in between 
groups. The correlation between Mn concentration and 
PCV was assessed by the Spearman’s rank correlation 
coefficient (rs). Statistical significance level was set at 
P < 0.05. Statistical analysis was performed with two 
commercial software packages (GraphPad InStat, 
version 3.10, GraphPad Software Inc.; and Minitab®, 
version 17.1.0, Minitab Inc.). 
Results 
A total of 1847 whole blood EDTA samples were 
available, from which 160 (8.7%) corresponded to dogs 
with histologically confirmed CE. Of these, anaemia 
was present in 33 (20.6%), with one patient being 
microcytic and hypochromic, and four normocytic and 
hypochromic. A cohort of the most anaemic dogs with 
CE (n = 11) was selected for Mn analysis, of which four 
had iron status results available, confirming absolute 
IDA in two, and anaemia of chronic disease (ACD) 
with relative IDA (low serum iron with normal 
transferrin saturation and low TIBC) in another two.  
Within the archived available whole blood EDTA 
samples, six corresponded to cases from which an iron 
status confirmed absolute ID. Of these, two dogs were 
in the previously selected CE group, and the remaining 
had an underlying diagnosis each of: intestinal 
lymphoma, immune-mediated haemolytic anaemia, 
urinary bladder mass, or suspected disseminated 
histiocytic neoplasia.  
Including the non-anaemic ill (n = 9, Table 1) and 
healthy (n = 12) cohort controls, a total of 36 samples 
were then prospectively analysed for Mn concentration.  
No differences were seen between groups with regard 
to age (P = 0.2025) or gender (P = 0.1025). Eight 
individuals were crossbreeds and the most commonly 
represented breeds included: Labrador Retriever (n = 
6), Cocker Spaniel (n = 4), followed by Boxer (n = 2), 
German Shepherd (n = 2), Hungarian Vizla (n = 2) and 
Springer Spaniel (n = 2). Mn concentrations and PCVs 
in each group are summarised in Figure 1 and Table 2. 
Manganese concentrations were significantly different 
between the four groups (P = 0.0001), being higher in 
healthy dogs compared to: anaemic dogs with CE (P = 
0.0056), dogs with IDA (P = 0.0001), and non-anaemic 
ill controls (P < 0.0001). No differences were observed 
between Mn concentrations in anaemic dogs with CE, 
dogs with IDA and non-anaemic ill controls. Mn 
concentrations were also higher in overall non-anaemic 
compared to anaemic dogs (P = 0.0078), with an overall 
moderate positive correlation between PCV and Mn 
concentration (rs = 0.6252, P < 0.0001).  
Table 1. Problem list/diagnoses of a cohort of non-anaemic 
ill dogs (n = 9). 
 
Diagnosis Patients (n) 
Chronic cystitis 2 
Chronic intermittent diarrhoea 2 
Acute gastroenteritis 1 
Cervical carcinoma, prostatic mass 1 
Hepatosplenic nodules, gastric mass, 
chronic kidney disease 
1 
Septic peritonitis of unknown origin 1 
Sinonasal aspergillosis 1 
 
Table 2. Descriptive statistics of manganese concentrations 
and packed cell values distribution within four cohorts. 
 
 Mn (nmol/L) PCV (l/l) 
Cohort Median Range Median Range 
Anaemic CE 366 219-1817 0.27 0.13-0.32 
IDA 292 170-710 0.20 0.13-0.30 
Non-
anaemic ill 
608 303-839 0.46 0.42-0.51 
Healthy 1006 893-1240 0.53 0.45-0.64 
Footnote: CE – chronic enteropathy; IDA – iron-deficiency anaemia; 
Mn – manganese; PCV – packed cell value. 
 
 
Fig. 1. Box and whisker plots and individual values depicting 
manganese (Mn) concentrations (left) and packed cell values 
(PCV, right) distribution within four cohorts. (CE): Chronic 
enteropathy; (IDA): Iron-deficiency anaemia. 
 
However, when analysing healthy dogs alone, there 
was no correlation between PCV and Mn (rs = -11.35, 
P = 0.7329). Moreover, when comparing PCV overall 
amongst groups, the difference obtained (P < 0.0001) 
was attributed only to the comparison between each of 
the anaemic groups (dogs with CE or ID), with each of 
the non-anaemic ill or healthy control groups, and no 
difference was seen in between the latter two cohorts 
on post-test Dunn’s multiple comparisons test.  
http://www.openveterinaryjournal.com 





Anaemia in canine CE was frequent within the 
population studied. The obtained prevalence of 20.6% 
was higher than previously reported, as was the overall 
number of patients assessed, totalling 160, compared 
with 22 and 77 in other studies (Craven et al., 2004; 
Marchetti et al., 2010). This prevalence is similar to 
that of 24% obtained in a meta-analysis in human IBD 
(Filmann et al., 2014). This confirms that anaemia is a 
common clinicopathological abnormality in canine CE 
and may be contributing towards overall morbidity. 
The results obtained in this study showed no evidence 
that ID is associated with increased whole blood Mn 
concentrations. Moreover, anaemic dogs with CE or 
IDA, as well as non-anaemic ill dogs, had lower Mn 
concentrations when compared to healthy controls.  
This does not support the hypothesis that Mn 
neurotoxicity contributes to the clinical sign of lethargy 
in these cases. 
There are many potential factors which may explain 
this result. As the majority of circulating Mn is within 
erythrocytes, it is possible that anaemia may be a 
confounding factor, although no correlation between 
Mn and PCV was found in the healthy controls (Pleban 
and Pearson, 1979).  
Measurement of whole blood Mn is recommended to 
reflect whole body manganese (Clegg et al., 1986). 
Whole blood Mn is less variable within an individual, 
when compared to plasma, better reflecting Mn in a 
single sample (Baker et al., 2015).  A higher risk of 
inaccuracy is seen with serum measurements, 
combined with wider variation of reference ranges 
(Baruthio et al., 1988). Even if no macroscopic 
haemolysis is present, there can be a considerable 
amount of Mn that is released from the red blood cells 
into the serum or plasma if not separated, leading to 
potential erroneous interpretations. In addition, to be 
reliable, serum or plasma analysis requires very 
sensitive assays, since Mn concentration is 
approximately 10-30 times lower than within 
erythrocytes (Versieck et al., 1974).  
Moreover, other studies have used whole blood 
samples to assess Mn status in ID and were able to 
confirm increased Mn concentrations in anaemic 
samples (Meltzer et al., 2010; Kim and Lee, 2011; 
Smith et al., 2013).  
Whole blood manganese is obtained from dietary 
intake.  These clinical cases were on a range of diets, 
which would likely have widely different Mn content, 
as previously documented on a comparison of several 
commercial diets (Gagne et al., 2013). Hyporexia is a 
common finding in any illness, and one of the main 
clinical signs of canine CE (Gianella et al., 2017), 
therefore reduced dietary intake is a potential 
confounding factor for both the non-anaemic ill and CE 
groups. The healthy control group dogs were all fed a 
standard complete diet with a Mn content of 25.1mg/kg 
on a dry matter basis, which is within the minimum and 
maximum amounts (5.8mg/kg and 170mg/kg, 
respectively) recommended for adult dogs, by the 
European Pet Food Industry Federation (Zentek, 2016).  
It is possible that this standardised diet may explain the 
higher concentrations seen in the healthy group in this 
study.    
Inflammation seen in canine CE might stimulate 
hepcidin, a peptide produced in the liver, controlling 
iron homeostasis by inhibiting iron transport (Brasse-
Lagnel et al., 2011). This hormone downregulates 
DMT1 and also binds to the iron and Mn exporter 
ferroportin 1, leading to its internalisation and 
degradation, resulting in iron (and likely Mn) 
entrapment and decreased transport across the 
basolateral membrane (Seo and Wessling-Resnick, 
2015). Hepcidin has been shown to be upregulated in 
human IBD, resulting in ACD due to relative ID 
(Bergamaschi et al., 2013). As a further variable, 
Vitamin D is an important suppressor of hepcidin, and 
dogs with severe CE have been shown to have reduced 
vitamin D concentrations (Gow et al., 2011; Bacchetta 
et al., 2014). Moreover, in inflammatory conditions, the 
action of metal transporters can be disrupted, 
independently of hepcidin (Guida et al., 2015). In 
human IBD, active disease was seen to correlate with 
decreased mucosal DMT1 expression (Wu et al., 2015). 
Conversely, in a study of human IBD, where 14/19 
patients were anaemic while in histological remission, 
upregulation of DMT1 was confirmed, and negatively 
correlated with haemoglobin, possibly explained by 
absolute ID overriding the effects of ACD (Sukumaran 
et al., 2014). Investigation of DMT1 expression in 
enterocytes in canine CE would help define this effect. 
In addition, is unknown how the presence of other iron 
and Mn transporters, namely ZIP8 and ZIP14, might 
influence overall canine Mn homeostasis (Shawki et 
al., 2015). Given that dogs with gastrointestinal disease 
(CE, lymphoma, and non-specified) were present 
within the absolute IDA and non-anaemic ill groups (n 
= 3 in each group), is possible that impaired Mn 
absorption in these patients has accounted for the lower 
concentrations observed, alongside the anaemic CE 
group.  
Finally, the liver is responsible for removing most of 
the Mn absorbed through the gastrointestinal tract from 
the portal circulation, excreting it via the biliary system 
and allowing only around 2% of the absorbed Mn to 
reach the systemic circulation (Papavasiliou et al., 
1966; Klaassen, 1974).  This system is very efficient 
and dogs fed large quantities of Mn over many weeks 
demonstrated no significant increase in whole blood 
manganese concentrations, yet had increased hepatic 
concentrations, thought to be due to trafficking through 
the liver for excretion in bile (Reiman and Minot, 
http://www.openveterinaryjournal.com 




1920). Therefore, it is possible that despite increased 
Mn delivery in the portal vasculature, the canine liver 
is more efficient at Mn extraction, leading to no 
systemic increase. Dogs with hepatic dysfunction and 
portosystemic shunting have altered Mn homeostasis, 
leading to Mn accumulation (Kilpatrick et al., 2014). 
Consequently, further research would be needed to 
assess if ID could play a role in exacerbating increased 
Mn concentrations in dogs with established liver 
pathology, as reported in human chronic liver disease 
(Malecki et al., 1999). 
This study carries several limitations. Although Mn 
levels were prospectively measured, the population was 
retrospectively assessed, thereby leading to lack of 
standardisation within and between groups. The 
number of dogs in each group was also small, which 
could have led to subsequent type II error regarding the 
absence of difference between anaemic and non-
anaemic ill dogs. Iron status analysis was only available 
for eight subjects, precluding further conclusions. In 
addition, diet was not standardised, which could have 
affected results (Lopez-Alonso et al., 2007).  
This study demonstrates that anaemia is common in 
dogs with chronic enteropathy. However, anaemic dogs 
with chronic enteropathy and/or iron-deficiency 
anaemia do not have increased whole blood manganese 
concentrations, compared to non-anaemic ill or healthy 
cohorts. More investigation is warranted to understand 
the complex interplay of canine anaemia, iron 
deficiency and inflammatory disease, namely chronic 
enteropathy, in manganese concentrations. 
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